SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001140361-22-004820
Filing Date
2022-02-11
Accepted
2022-02-11 15:39:26
Documents
1
Group Members
BASSO GP, LLCBASSO MANAGEMENT, LLCBASSO SPAC FUND LLCHOWARD I. FISCHER

Document Format Files

Seq Description Document Type Size
1 SC 13G/A brhc10033667_13ga.htm SC 13G/A 176068
  Complete submission text file 0001140361-22-004820.txt   178155
Mailing Address 1266 EAST MAIN STREET 4TH FLOOR STAMFORD CT 06902
Business Address 1266 EAST MAIN STREET 4TH FLOOR STAMFORD CT 06902 (203) 352-6100
BASSO CAPITAL MANAGEMENT, L.P. (Filed by) CIK: 0001287978 (see all company filings)

IRS No.: 200406508 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Subject) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92283 | Film No.: 22620248
SIC: 2836 Biological Products, (No Diagnostic Substances)